Effect of polymorphism in the human glutathione S-transferase A1 promoter on hepatic GSTA1 and GSTA2 expression

Brian Coles(National Center for Toxicological Research), Fred F. Kadlubar(Courtauld Institute of Art), Candee H. Teitel(National Center for Toxicological Research), Mihi Yang(National Center for Toxicological Research), Nicholas P. Lang(John L. McClellan Memorial Veterans Hospital), Wolfgang W. Huber, Claudine Rauch(Inserm), Fabrice Morel(Université de Rennes), Bridgett Green(National Center for Toxicological Research)
Pharmacogenetics
November 1, 2001
10.1097/00008571-200111000-00004
Cited by 224

Related Papers

Human cytochrome P-450PA (P-450IA2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines.
|Proceedings of the National Academy of Sciences|1989|638
Determination of CYP1A2 and NAT2 phenotypes in human populations by analysis of caffeine urinary metabolites
|Pharmacogenetics|1992|418
Rapid metabolic phenotypes for acetyltransferase and cytochrome P4501A2 and putative exposure to food-borne heterocyclic amines increase the risk for colorectal cancer or polyps.
|PubMed|1994|392
Metabolic activation of carcinogenic heterocyclic aromatic amines by human liver and colon
|Carcinogenesis|1991|342
Hepatic microsomal N-glucuronidation and nucleic acid binding of N-hydroxy arylamines in relation to urinary bladder carcinogenesis.
|PubMed|1977|325